S&P 500   4,179.83
DOW   32,908.27
QQQ   347.99
Stock market today: Global shares mostly rise after House approves debt ceiling deal
We Called (ARWR) In Advance, Which Stocks Are Next? (Ad)
Alibaba Unveils Its Spin-Off Plans
The Most Upgraded Stocks From The Q1 Earnings Season
Major Financial Crisis Could Hit America (Ad)
Oman launches $5B investment fund as part of efforts to diversify oil-dependant economy
Can the Dow's 2023 Runaway Winners Keep Running?
Major Financial Crisis Could Hit America (Ad)
KLA Shares Soars As Chip Equipment Makers Surge 21% In May
Can These Two Crypto Stocks Stage a Comeback?
S&P 500   4,179.83
DOW   32,908.27
QQQ   347.99
Stock market today: Global shares mostly rise after House approves debt ceiling deal
We Called (ARWR) In Advance, Which Stocks Are Next? (Ad)
Alibaba Unveils Its Spin-Off Plans
The Most Upgraded Stocks From The Q1 Earnings Season
Major Financial Crisis Could Hit America (Ad)
Oman launches $5B investment fund as part of efforts to diversify oil-dependant economy
Can the Dow's 2023 Runaway Winners Keep Running?
Major Financial Crisis Could Hit America (Ad)
KLA Shares Soars As Chip Equipment Makers Surge 21% In May
Can These Two Crypto Stocks Stage a Comeback?
S&P 500   4,179.83
DOW   32,908.27
QQQ   347.99
Stock market today: Global shares mostly rise after House approves debt ceiling deal
We Called (ARWR) In Advance, Which Stocks Are Next? (Ad)
Alibaba Unveils Its Spin-Off Plans
The Most Upgraded Stocks From The Q1 Earnings Season
Major Financial Crisis Could Hit America (Ad)
Oman launches $5B investment fund as part of efforts to diversify oil-dependant economy
Can the Dow's 2023 Runaway Winners Keep Running?
Major Financial Crisis Could Hit America (Ad)
KLA Shares Soars As Chip Equipment Makers Surge 21% In May
Can These Two Crypto Stocks Stage a Comeback?
S&P 500   4,179.83
DOW   32,908.27
QQQ   347.99
Stock market today: Global shares mostly rise after House approves debt ceiling deal
We Called (ARWR) In Advance, Which Stocks Are Next? (Ad)
Alibaba Unveils Its Spin-Off Plans
The Most Upgraded Stocks From The Q1 Earnings Season
Major Financial Crisis Could Hit America (Ad)
Oman launches $5B investment fund as part of efforts to diversify oil-dependant economy
Can the Dow's 2023 Runaway Winners Keep Running?
Major Financial Crisis Could Hit America (Ad)
KLA Shares Soars As Chip Equipment Makers Surge 21% In May
Can These Two Crypto Stocks Stage a Comeback?

Praxis Precision Medicines (PRAX) Earnings Date, Estimates & Call Transcripts

$0.86
-0.01 (-1.15%)
(As of 05/31/2023 ET)
Compare
Today's Range
$0.86
$0.96
50-Day Range
$0.80
$1.12
52-Week Range
$0.79
$9.01
Volume
459,472 shs
Average Volume
590,949 shs
Market Capitalization
$53.39 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.50
Skip Charts & View Estimated and Actual Earnings Data

PRAX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

PRAX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Praxis Precision Medicines Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20234($1.21)($0.58)($0.83)
Q2 20234($1.16)($0.59)($0.75)
Q3 20234($1.12)($0.43)($0.69)
Q4 20234($1.13)($0.30)($0.68)
FY 202316($4.62)($1.90)($2.95)
Q1 20241($0.27)($0.27)($0.27)
Q2 20241($0.25)($0.25)($0.25)
Q3 20241($0.25)($0.25)($0.25)
Q4 20241($0.25)($0.25)($0.25)
FY 20244($1.02)($1.02)($1.02)

PRAX Earnings Date and Information

Praxis Precision Medicines has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 14th, 2023 based off prior year's report dates.

Praxis Precision Medicines Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/14/2023
(Estimated)
        
2/7/2023Q4 2022($0.73)($0.87)($0.14)($0.87)
11/9/2022Q3 2022($0.92)($0.96)($0.04)($0.96)
8/8/2022Q2 2022($1.30)($1.32)($0.02)($1.32)
5/9/2022Q1 2022($1.29)($1.51)($0.22)($1.51)      
2/28/2022Q4 2021($1.08)($1.30)($0.22)($1.30)    
11/3/20219/30/2021($0.93)($1.00)($0.07)($1.00)  
8/16/20216/30/2021($0.68)($0.88)($0.20)($0.88)
5/11/2021Q1($0.7430)($0.71)+$0.0330($0.71)
3/16/2021Q4($0.3750)($0.87)($0.4950)($0.87)  
11/23/2020Q3 2020($12.10)($12.10)($12.10)












Praxis Precision Medicines Earnings - Frequently Asked Questions

When is Praxis Precision Medicines's earnings date?

Praxis Precision Medicines has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 14th, 2023 based off last year's report dates. Learn more on PRAX's earnings history.

How much profit does Praxis Precision Medicines generate each year?

Praxis Precision Medicines (NASDAQ:PRAX) has a recorded net income of -$214.03 million. PRAX has generated -$3.86 earnings per share over the last four quarters.

What is Praxis Precision Medicines's EPS forecast for next year?

Praxis Precision Medicines's earnings are expected to grow from ($2.69) per share to ($2.22) per share in the next year.

More Earnings Resources from MarketBeat

This page (NASDAQ:PRAX) was last updated on 6/1/2023 by MarketBeat.com Staff

My Account -